πŸ‡ΊπŸ‡Έ FDA
Patent

US 8119655

Kinase inhibitors

granted A61PA61P1/04A61P15/18

Quick answer

US patent 8119655 (Kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P15/18, A61P17/06, A61P17/14